Hellmut Samonigg

9.8k total citations · 2 hit papers
118 papers, 6.6k citations indexed

About

Hellmut Samonigg is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Hellmut Samonigg has authored 118 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 42 papers in Cancer Research and 34 papers in Molecular Biology. Recurrent topics in Hellmut Samonigg's work include Breast Cancer Treatment Studies (19 papers), Estrogen and related hormone effects (11 papers) and Genetic factors in colorectal cancer (10 papers). Hellmut Samonigg is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Estrogen and related hormone effects (11 papers) and Genetic factors in colorectal cancer (10 papers). Hellmut Samonigg collaborates with scholars based in Austria, United States and Germany. Hellmut Samonigg's co-authors include Armin Gerger, Michael Gnant, R. Jakesz, Martin Pichler, Peter Krippl, Thomas Bauernhofer, Wilfried Renner, Uwe Langsenlehner, W. Kwasny and Joanna Szkandera and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Hellmut Samonigg

116 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

2005 642 citations R. Jakesz, Michael Gnant et al. profile →
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer

2013 413 citations Michael Stotz, Armin Gerger et al. profile →

Peers

Countries citing papers authored by Hellmut Samonigg

Since Specialization

Citations

This map shows the geographic impact of Hellmut Samonigg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hellmut Samonigg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hellmut Samonigg more than expected).

Fields of papers citing papers by Hellmut Samonigg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hellmut Samonigg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hellmut Samonigg. The network helps show where Hellmut Samonigg may publish in the future.

Co-authorship network of co-authors of Hellmut Samonigg

This figure shows the co-authorship network connecting the top 25 collaborators of Hellmut Samonigg. A scholar is included among the top collaborators of Hellmut Samonigg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hellmut Samonigg. Hellmut Samonigg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	MiR‐96‐5p influences cellular growth and is associated with poor survival in colorectal cancer patients 2014 ·Molecular Carcinogenesis ·Anna Lena Ress, Verena Stiegelbauer, Elke Winter, Daniela Schwarzenbacher, Tobias Kiesslich, Sigurd Lax, (unknown), Alexander Deutsch, Thomas Bauernhofer, Hui Ling, Hellmut Samonigg, Armin Gerger, Gerald Höefler, Martin Pichler	68
2	The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients 2014 ·The American Journal of Surgery ·Joanna Szkandera, Armin Gerger, Bernadette Liegl‐Atzwanger, Michael Stotz, Hellmut Samonigg, Joerg Friesenbichler, Tatjana Stojaković, Andreas Leithner, Martin Pichler	40
3	miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor 2013 ·Journal of Clinical Pathology ·Martin Pichler, Elke Winter, Anna Lena Ress, Thomas Bauernhofer, Armin Gerger, Tobias Kiesslich, Sigurd Lax, Hellmut Samonigg, Gerald Höefler	83
4	Complex Tumor Genomes Inferred from Single Circulating Tumor Cells by Array-CGH and Next-Generation Sequencing 2013 ·Cancer Research ·Ellen Heitzer, Martina Auer, Christin Gasch, Martin Pichler, Peter Ulz, Eva Maria Hoffmann, Sigurd Lax, Julie Waldispuehl‐Geigl, Oliver Mauermann, Carolin Lackner, Gerald Höfler, Florian Eisner, Heinz Sill, Hellmut Samonigg, Klaus Pantel, Sabine Riethdorf, Thomas Bauernhofer, Jochen B. Geigl, Michael R. Speicher	403
5	A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early‐stage breast cancer 2013 ·Molecular Carcinogenesis ·Gudrun Absenger, Joanna Szkandera, Michael Stotz, Martin Pichler, Thomas Winder, Tanja Langsenlehner, Uwe Langsenlehner, Hellmut Samonigg, Wilfried Renner, Armin Gerger	12
6	Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing 2013 ·Genome Medicine ·Ellen Heitzer, Peter Ulz, Jelena Belic, (unknown), Franz Quehenberger, Katja Fischereder, Theresa Benezeder, Martina Auer, (unknown), Sebastian Mannweiler, Martin Pichler, Florian Eisner, Martin Haeusler, Sabine Riethdorf, Klaus Pantel, Hellmut Samonigg, Gerald Höefler, Herbert Augustin, Jochen B. Geigl, Michael R. Speicher	263
7	Novel Immunofluorescence Protocol for Multimarker Assessment of Putative Disseminating Breast Cancer Stem Cells 2010 ·Applied immunohistochemistry & molecular morphology ·Marija Balić, (unknown), Stefanie Stanzer, Henry Lin, (unknown), Joanna Szkandera, Maria Grazia Daidone, Hellmut Samonigg, Richard J. Côté, Nadia Dandachi	37
8	Evaluation of High-Resolution Melting Analysis as a Diagnostic Tool to Detect the BRAF V600E Mutation in Colorectal Tumors 2009 ·Journal of Molecular Diagnostics ·Martin Pichler, Marija Balić, Elke Stadelmeyer, Christoph Ausch, (unknown), Christian Guelly, Thomas Bauernhofer, Hellmut Samonigg, Gerald Höefler, Nadia Dandachi	84
9	Association of interleukin-10 gene variation with breast cancer prognosis 2009 ·Breast Cancer Research and Treatment ·Armin Gerger, Wilfried Renner, Tanja Langsenlehner, Günter Hofmann, (unknown), Joanna Szkandera, Hellmut Samonigg, Peter Krippl, Uwe Langsenlehner	39
10	High Quality Assessment of DNA Methylation in Archival Tissues from Colorectal Cancer Patients Using Quantitative High-Resolution Melting Analysis 2009 ·Journal of Molecular Diagnostics ·Marija Balić, Martin Pichler, (unknown), Ellen Heitzer, Christoph Ausch, Hellmut Samonigg, Richard J. Côté, Nadia Dandachi	47
11	Optimization of Diagnostic Elisa - Based Tests for the Detection of Auto-Antibodies Against Tumor Antigens in Human Serum 2008 ·Bosnian Journal of Basic Medical Sciences ·(unknown), Monika Riederer, Marija Balić, Nadia Dandachi, Stefanie Stanzer, (unknown), (unknown), (unknown), Hellmut Samonigg, Thomas Bauernhofer	11
12	Humoral immune response to linear EpCAM-peptides induced by the mimotope cancer vaccine IGN101: Assessment by two independent methods 2007 ·Cancer Research ·Astrid Dürauer, Hans Loibner, Manfred Schuster, Thomas Bauernhofer, Hellmut Samonigg, Alois Jungbauer	1
13	Asymptomatic Primary Malignant Melanoma of the Esophagus 2007 ·Oncology Research and Treatment ·Armin Gerger, Freyja‐Maria Smolle‐Jüttner, Hellmut Samonigg, (unknown), Josef Smolle	11
14	Global quality of life and its potential predictors in breast cancer patients: an exploratory study 2006 ·Supportive Care in Cancer ·Elisabeth Andritsch, (unknown), Günter Hofmann, (unknown), Hellmut Samonigg	43
15	Palliative Sedierung—eine Alternative zur Euthanasie bei unerträglichem Leid am Ende des Lebens? 2005 ·Medizinische Klinik ·M. Weber, Imke Strohscheer, Hellmut Samonigg, Christoph Huber	3
16	Change of HER‐2/neu status in a subset of distant metastases from breast carcinomas 2004 ·The Journal of Pathology ·Peter Regitnig, Walter Schippinger, (unknown), Hellmut Samonigg, Sigurd Lax	105
17	Incidence of Anaemia in Breast Cancer Patients Receiving Adjuvant Chemotherapy 2003 ·Breast Cancer Research and Treatment ·Ursula Denison, (unknown), C Peters-Engl, Hellmut Samonigg, Peter Krippl, Alois Lang, Andreas Obermair, Helga Wagner, P. Sevelda	20
18	Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. 2002 ·PubMed ·Monika Schindl, Sebastian F. Schoppmann, Hellmut Samonigg, H. Hausmaninger, W. Kwasny, Michael Gnant, R. Jakesz, E. Kubista, Peter Birner, Georg Oberhuber	332
19	Sequential treatment of recurrent mesenteric desmoid tumor 1996 ·Cancer ·Thomas Bauernhofer, Herbert Stöger, Marianne Schmid, M.G. Smola, (unknown), Gerald Höfler, G. Ranner, Emil C. Reisinger, Hellmut Samonigg	6
20	Sequential treatment of recurrent mesenteric desmoid tumor 1996 ·Cancer ·Thomas Bauernhofer, Herbert Stöger, (unknown), M.G. Smola, (unknown), Gerald Höfler, G. Ranner, Emil C. Reisinger, Hellmut Samonigg	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact